Cargando…

A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients

BACKGROUND: This study compared everolimus and mycophenolate mofetil, each paired with calcineurin inhibitors (CNIs) and used with or without steroids, for maintaining immunosuppression in kidney transplant (KT) patients. METHODS: Relevant studies published before August 21, 2022 were retrieved from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vergara-Rejante, Larraine, Tanhui, Kristel K., Alolod, Maria Kristina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Transplantation 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090833/ https://www.ncbi.nlm.nih.gov/pubmed/37064769 http://dx.doi.org/10.4285/kjt.23.0003

Ejemplares similares

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients
por: Pacheco, Larissa Sgaria, et al.
Publicado: (2018)

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
por: Xie, Xishao, et al.
Publicado: (2015)

A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials
por: DENG, Jin, et al.
Publicado: (2021)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage
por: Crane, Genevieve M., et al.
Publicado: (2015)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
por: Sterneck, M, et al.
Publicado: (2014)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Case Report of COVID-19 Infection After Kidney Transplant Treated With Casirivimab-Imdevimab and Mycophenolate Mofetil Changed to Everolimus
por: Kijima, Yu, et al.
Publicado: (2022)

Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE
por: van Gelder, Teun, et al.
Publicado: (2021)

Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study
por: Watarai, Yoshihiko, et al.
Publicado: (2021)

Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
por: Wang, Pusen, et al.
Publicado: (2017)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
por: Sayilar, Emel Isiktas, et al.
Publicado: (2022)

Everolimus with or without mycophenolate mofetil in a liver transplantation setting: a single-center experience
por: Cholongitas, Εvangelos, et al.
Publicado: (2018)

Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
por: Kong, Yuan, et al.
Publicado: (2011)

Everolimus/mycophenolate-mofetil: COVID-19 pneumonia: case report
Publicado: (2021)

Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study
por: Saliba, Faouzi, et al.
Publicado: (2022)

Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
por: Beckebaum, Susanne, et al.
Publicado: (2010)

Stepwise Reduction of Mycophenolate Mofetil with Conversion to Everolimus for the Treatment of Active BKV in Kidney Transplant Recipients: A Single-Center Experience in Vietnam
por: Kien, Truong Quy, et al.
Publicado: (2022)

Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
por: Brunkhorst, Lena Caroline, et al.
Publicado: (2015)

The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial
por: Van Keer, Jan, et al.
Publicado: (2017)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis
por: Melancon, Keith, et al.
Publicado: (2013)

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens
por: de Boer, Silke E., et al.
Publicado: (2022)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation
por: Suginobe, Hidehiro, et al.
Publicado: (2017)

A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation
por: Nickerson, Peter W., et al.
Publicado: (2020)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study
por: Noreikaitė, Aurelija, et al.
Publicado: (2017)

Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney
por: Descazeaud, Virginie, et al.
Publicado: (2012)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
por: Traitanon, Opas, et al.
Publicado: (2019)

Calcineurin inhibitor toxicity in a renal transplant recipient
por: Charney, Douglas A., et al.
Publicado: (2009)

Transfer of Everolimus into Colostrum of a Kidney Transplant Mother
por: Kociszewska-Najman, Bożena, et al.
Publicado: (2017)

Calcineurin inhibitor-induced pain syndrome after kidney transplantation—a rare but disabling condition
por: Breitenstein, Alexander, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c1m5ki4v04uv8glagd3if1plei